ARANOTE trial

preview_player
Показать описание
In this interview, Assoc. Prof. Francesco Sanguedolce (IT) discusses the ARANOTE trial, including the design and inclusion criteria, and key findings with UROONCO PCa Assoc. Prof. Rajwa.
  1. European Association of Urology
  2. prostate cancer
  3. oncology
Рекомендации по теме
ARANOTE trial 0:08:40

ARANOTE trial

Assessing the ARANOTE 0:06:11

Assessing the ARANOTE Trial: Role of Darolutamide in Enhancing ADT for HSPC

Insights from ARANOTE 0:21:33

Insights from ARANOTE and PEACE 3 Trials: Optimizing Prostate Cancer Treatment

Dr Saad on 0:01:15

Dr Saad on the Safety Profile of Darolutamide Plus ADT in mHSPC

How the ARANOTE 0:18:06

How the ARANOTE Trial Results Could Advance Prostate Cancer Treatment

Exclusive interview on 0:05:47

Exclusive interview on ARANOTE study: PSA response with darolutamide plus ADT in patients with mHSPC

Treatment Considerations After 0:08:03

Treatment Considerations After New Data: ARASENS, ARANOTE, and PEACE-3

Evolving Role of 0:12:46

Evolving Role of Bone Health and Radiopharmaceuticals in Prostate Cancer Care

Prostate Cancer Highlights: 0:30:50

Prostate Cancer Highlights: Expert Review of European Oncology Meeting

ARASENS: dialuramide plus 0:01:56

ARASENS: dialuramide plus ADT and docetaxel for metastatic hormone-sensitive prostate cancer

ARAMON: darolutamide versus 0:02:12

ARAMON: darolutamide versus enzalutamide monotherapy in CSPC

🚨Episode 14 is 0:00:51

🚨Episode 14 is now LIVE and we can’t wait for you to listen

ESMO24# Prostate Cancer 0:45:40

ESMO24# Prostate Cancer Highlights | Reaction from China

ESMO 2024 Prostate 0:27:32

ESMO 2024 Prostate Cancer Highlights

Individualizing Prostate Cancer 1:25:44

Individualizing Prostate Cancer Management

Episode 154: New 0:40:38

Episode 154: New Drug Approvals for Metastatic Castration-Sensitive Prostate Cancer

Prostate Cancer - 0:18:16

Prostate Cancer - New Study Results (Part 2)

4/12/2022 Hi-Risk/Recurrent/Advanced PCa 2:09:35

4/12/2022 Hi-Risk/Recurrent/Advanced PCa Men & Caregiver

Watch Dr. Alicia 1:29:44

Watch Dr. Alicia K. Morgans discuss #ProstateCancer updates from #GU25 - bit.ly/Prostate-SF25Y

Dr Park on 0:04:34

Dr Park on Patient and Disease Factors that Affect Treatment Decisions for mHSPC

Navigating Therapeutic Decision 1:01:42

Navigating Therapeutic Decision Making in Prostate Cancer

Skills Lab: Clinical 0:13:16

Skills Lab: Clinical Trial Methods — Focus on the Control Arm

Advances in Prostate 0:08:41

Advances in Prostate Cancer Treatment: Insights from Prof. Suneil Jain | Sciensus

133. ESMO 2024 0:33:44

133. ESMO 2024 - Genitourinary Cancers with Prof Anthony Joshua